关于“NUC-1031 联合顺铂一线治疗晚期胆管癌患者的 Ib 期研究（ABC-08）”。
In Regard to "A Phase Ib Study of NUC-1031 in Combination with Cisplatin for the First-Line Treatment of Patients with Advanced Biliary Tract Cancer (ABC-08)".
机构信息
Department of Experimental, Diagnostic, and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, Italy.
出版信息
Oncologist. 2021 May;26(5):e902. doi: 10.1002/onco.13703. Epub 2021 Feb 15.
Abstract
This letter to the editor remarks on a recently published article on the use of NUC‐1031 and cisplatin for patients with biliary tract cancer and compares results of the landmark ABC‐02 trial.
摘要
这封给编辑的信评论了最近发表的一篇关于 NUC‐1031 和顺铂用于胆管癌患者的文章，并比较了里程碑式的 ABC‐02 试验的结果。
相似文献
1
In Regard to "A Phase Ib Study of NUC-1031 in Combination with Cisplatin for the First-Line Treatment of Patients with Advanced Biliary Tract Cancer (ABC-08)".关于“NUC-1031 联合顺铂一线治疗晚期胆管癌患者的 Ib 期研究（ABC-08）”。
Oncologist. 2021 May;26(5):e902. doi: 10.1002/onco.13703. Epub 2021 Feb 15.
2
A Phase Ib Study of NUC-1031 in Combination with Cisplatin for the First-Line Treatment of Patients with Advanced Biliary Tract Cancer (ABC-08).NUC-1031 联合顺铂一线治疗晚期胆道癌（ABC-08）的 Ib 期研究。
Oncologist. 2021 Apr;26(4):e669-e678. doi: 10.1002/onco.13598. Epub 2020 Dec 3.
3
NUC-1031 in biliary tract cancer: from bench to bedside and back?NUC-1031 在胆管癌中的研究：从基础到临床，再回来？
Cancer Chemother Pharmacol. 2020 Jun;85(6):1011-1014. doi: 10.1007/s00280-020-04080-6. Epub 2020 May 31.
4
Capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer: a retrospective single-center study.卡培他滨联合顺铂一线治疗晚期胆道癌：一项回顾性单中心研究。
Chemotherapy. 2012;58(3):225-32. doi: 10.1159/000339499. Epub 2012 Jul 21.
5
Prognostic factors for progression-free and overall survival in advanced biliary tract cancer.晚期胆道癌患者无进展生存期和总生存期的预后因素。
Ann Oncol. 2016 Jan;27(1):134-40. doi: 10.1093/annonc/mdv483. Epub 2015 Oct 19.
6
Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I study.在晚期癌症患者中，首创类药物 NUC-1031 的抗肿瘤活性：I 期研究结果。
Br J Cancer. 2018 Oct;119(7):815-822. doi: 10.1038/s41416-018-0244-1. Epub 2018 Sep 12.
7
Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced biliary cancer.卡培他滨联合顺铂作为晚期胆管癌一线化疗的II期研究。
Ann Oncol. 2003 Jul;14(7):1115-20. doi: 10.1093/annonc/mdg281.
8
New developments in systemic therapy for advanced biliary tract cancer.晚期胆道癌系统治疗的新进展。
Jpn J Clin Oncol. 2018 Aug 1;48(8):703-711. doi: 10.1093/jjco/hyy082.
9
Surgical treatment for non-dilated biliary tract with pancreaticobiliary maljunction should include excision of the extrahepatic bile duct.对于合并胰胆管合流异常的非扩张性胆管的手术治疗应包括肝外胆管切除术。
Hepatogastroenterology. 2001 Jul-Aug;48(40):984-7.
10
Combined chemotherapy of irinotecan and low-dose cisplatin (I/low-P) against metastatic biliary tract cancer.伊立替康与低剂量顺铂联合化疗（I/低剂量P）治疗转移性胆管癌。
J Hepatobiliary Pancreat Surg. 2006;13(5):463-7. doi: 10.1007/s00534-006-1098-0.
引用本文的文献
1
Elevated 2-oxoglutarate antagonizes DNA damage responses in cholangiocarcinoma chemotherapy through regulating aspartate beta-hydroxylase.琥珀酸脱氢酶通过调节天冬氨酸β-羟化酶升高 2-氧戊二酸拮抗胆管癌化疗中的 DNA 损伤反应。
Cancer Lett. 2024 Jan 1;580:216493. doi: 10.1016/j.canlet.2023.216493. Epub 2023 Nov 15.
2
Targeted Therapies in Advanced Cholangiocarcinoma: A Focus on FGFR Inhibitors.晚期胆管癌的靶向治疗：聚焦 FGFR 抑制剂。
Medicina (Kaunas). 2021 May 8;57(5):458. doi: 10.3390/medicina57050458.
3
In Reply.作为回复。
Oncologist. 2021 May;26(5):e903-e904. doi: 10.1002/onco.13704. Epub 2021 Feb 15.
本文引用的文献
1
A Phase Ib Study of NUC-1031 in Combination with Cisplatin for the First-Line Treatment of Patients with Advanced Biliary Tract Cancer (ABC-08).NUC-1031 联合顺铂一线治疗晚期胆道癌（ABC-08）的 Ib 期研究。
Oncologist. 2021 Apr;26(4):e669-e678. doi: 10.1002/onco.13598. Epub 2020 Dec 3.
2
NUC-1031/cisplatin versus gemcitabine/cisplatin in untreated locally advanced/metastatic biliary tract cancer (NuTide:121).NUC-1031/顺铂对比吉西他滨/顺铂治疗未经治疗的局部晚期/转移性胆道癌（NuTide：121）。
Future Oncol. 2020 Jun;16(16):1069-1081. doi: 10.2217/fon-2020-0247. Epub 2020 May 6.
3
New Horizons for Precision Medicine in Biliary Tract Cancers.胆道肿瘤精准医学的新视野。
Cancer Discov. 2017 Sep;7(9):943-962. doi: 10.1158/2159-8290.CD-17-0245. Epub 2017 Aug 17.
4
Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma.胆管癌不同病因亚型的全基因组和表观基因组景观。
Cancer Discov. 2017 Oct;7(10):1116-1135. doi: 10.1158/2159-8290.CD-17-0368. Epub 2017 Jun 30.
5
Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.顺铂联合吉西他滨与吉西他滨治疗胆管癌。
N Engl J Med. 2010 Apr 8;362(14):1273-81. doi: 10.1056/NEJMoa0908721.
Zotero 插件